Study summary · research use only
Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthood
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This human study evaluated GH responses to GHRP-6 or GHRH, alone or combined, in healthy young and late-adulthood subjects. His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6) is described as a synthetic compound that releases GH. Subjects underwent three tests in random order after an overnight fast; GHRH (100 micrograms), GHRP-6 (90 micrograms), alone or combined, were administered as an i.v. bolus. Groups were young (22 +/- 1.1 years, n = 9) and older (59.5 +/- 1.7 years, n = 9). Serum GH was measured by radioimmunoassay. The abstract reports combined administration elicited a greater GH increase than either alone in both groups; GH responses to GHRH were greater in younger subjects, while responses to GHRP-6 or combined administration did not differ significantly between groups.
Abstract
Growth hormone (GH) secretion in middle and late adulthood declines with age. However, the precise mechanisms causing this impairment in GH release are unknown. His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 (GHRP-6) is a synthetic compound that releases GH in a dose related and specific manner in several species, including man. In order to gain a further insight into disrupted GH secretion in late adulthood, we evaluated GH responses to GHRP-6 or GHRH, administered either alone or in combination, in healthy young and late adulthood groups of subjects. All subjects underwent three different tests carried out in random order and separated by at least one week. Tests were performed at 0900 h after an overnight fast. GHRH (100 micrograms), GHRP-6 (90 micrograms) either alone or in combination were administered as an i.v. bolus. Groups of healthy young (mean +/- SEM 22 +/- 1.1 years, n = 9) and older adult subjects (59.5 +/- 1.7 years, n = 9) were studied. Serum GH levels were measured by radioimmunoassay. In the group of young adult subjects the combined administration of GHRH and GHRP-6 elicited a greater GH increase than GHRH alone (F = 21.9, P < 0.001) or GHRP-6 alone (F = 6.2, P = 0.01). Similarly, the response to the combined stimuli was also greater than with GHRH alone (F = 21.8, P < 0.001) or GHRP-6 alone (F = 23.9, P < 0.001) in the late adulthood group of subjects. GH responses to GHRH were greater in younger than in older subjects (F = 3.45, P = 0.03). In contrast, GH responses to either GHRP-6 (F = 0.71, P = NS) or combined GHRH plus GHRP-6 administration (F = 0.68, P = NS) were not significantly different between the two groups. These data show that GH responses to GHRP-6 are much greater than to GHRH in late adulthood. The marked increase of plasma GH levels observed after administration of GHRP-6 alone or in combination with GHRH indicates that impaired GH secretion in late adulthood is a functional and potentially reversible state.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.